Delivery Order SPE2DB20D3103-SPE2DB25FP7D1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,281.50 to AmerisourceBergen Drug Corp for ALBUKED-25 VIAL 100ML on July 26, 2025, with an ultimate completion date of August 15, 2025. This firm fixed price delivery order, placed without set-aside designation, will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,152.50 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ALBUKED-25 vials. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to provide pharmaceutical products and medical supplies to support Department of Defense military treatment programs and...
- The Defense Logistics Agency awarded a $1,210.55 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of ALBUKED-5 VIAL 250ML, a pharmaceutical product. This firm fixed price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $6,231.00 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has an ultimate completion date of January 26, 2024, is for the procurement of ALBUKED-5 VIAL 250ML medical products. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical. The...
- This federal contract award to Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, is a delivery order valued at $1,100.00 for the product "ALBUKED-25 VIAL 50ML". The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. Amerisourcebergen Drug Corp is the prime contractor and has received numerous similar awards from DLA to supply pharmaceuticals, medical supplies,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,869.30 to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to Amerisourcebergen Drug Corp to provide pharmaceuticals, medical supplies, and related distribution services to support military treatment...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $1,100.00 firm fixed-price delivery order is for the supply of ALBUKED-25 VIAL 50ML pharmaceutical products. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This IDC serves as...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,320.60 contract is for the delivery of ALBUKED-5 VIAL 250ML medical supplies, with a completion date of July 9, 2025. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a global pharmaceutical support...
- This federal contract award, valued at $3,536.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ALBUKED-25 VIAL 100ML, a medical product. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is October 3, 2022. The contract does not have a set-aside designation, indicating it was open to full and open...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $4,305.00 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564096103 ! ALBUKED-25 VIAL 100ML. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP7D1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,140.75 to AmerisourceBergen Drug Corp for the supply of ALBUKED-25 VIAL 100ML, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, leverages this IDC to supply an extensive portfolio of medications, vaccines, medical devices, and specialized healthcare commodities to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The underlying SPE2DX contract enables flexible delivery orders across multiple therapeutic domains to support military personnel and healthcare operations worldwide. This particular delivery order exemplifies the company's role as a critical vendor in the federal medical procurement supply chain, fulfilling routine pharmaceutical commodity needs through the DLA's established procurement framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/31/25 |